Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mycronic AB ( (SE:MYCR) ) just unveiled an update.
Mycronic has secured a replacement order from an existing Asian customer for a Prexision 8 Evo mask writer, a system designed to handle complex patterns for advanced display photomasks, with an order value estimated between USD 21 million and USD 24 million and delivery scheduled for the first quarter of 2027. The deal underscores the continued success of Mycronic’s trade-in program, which encourages customers to modernize their installed base, reinforcing the company’s position in the display and semiconductor equipment market and signaling ongoing demand for its high-end pattern generation technology.
The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK229.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.
More about Mycronic AB
Mycronic is a Swedish high-tech company that develops, manufactures and markets high-precision, flexible production equipment for the electronics industry. Through its Pattern Generators division, the company supplies mask writers and metrology systems used in display manufacturing and semiconductor production, serving a global customer base from its headquarters in Täby and subsidiaries across Europe, Asia and the Americas.
Average Trading Volume: 192,497
Technical Sentiment Signal: Buy
Current Market Cap: SEK40.96B
For a thorough assessment of MYCR stock, go to TipRanks’ Stock Analysis page.